Skip to content
‹ Back to IndustriesHealthcare

Interoperability Can’t Have a “One-Size-Fits-All” Solution to Support Health Equity Goals

At HIMSS 2023, health equity couldn’t have been a more important focus for companies across every slice of the healthcare ecosystem. And with healthcare going through its own Industry 4.0 revolution with mass adoption of medtech, telehealth services, and cloud services, it’s becoming clearer that health equity needs to intersect with goals for technology…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

At HIMSS 2023, health equity couldn’t have been a more important focus for companies across every slice of the healthcare ecosystem. And with healthcare going through its own Industry 4.0 revolution with mass adoption of medtech, telehealth services, and cloud services, it’s becoming clearer that health equity needs to intersect with goals for technology interoperability if it’s to be an achievable and realistic vision for healthcare.

Interoperability, the coordinated exchange of data between different information systems, devices, and applications, plays a crucial role in advancing health equity by addressing the digital divide and social determinants of health. By ensuring broad interoperability of health data, patients and caregivers can better plan care, regardless of the platform or device used.

Interoperability is making progress on some fronts, while at the same time revealing itself as sorely lacking in other sides of the healthcare ecosystem. Among hospitals, interoperability has seen significant improvement in recent years, with 88% of hospitals as of 2021 engaged in electronically sending and obtaining patient health information. Despite this progress, rural hospitals haven’t been able to keep up, leaving huge swaths of already underserved populations further behind in the care gap. Interoperability is also proving to be a crucial element in the deployment of home health programs, facilitating a comprehensive view of patient health, streamlined workflows, and improved efficiency.

If health equity and interoperability are so critical for the future of a more effective and efficient healthcare system in the U.S., what else needs to be done to get advancing medical technology working together? What does this interoperability ecosystem need to look like to support health equity goals? John Nebergall, COO at Consensus Cloud Solutions, gave his take on the development of interoperability in healthcare. In his eyes, conversations have been steering the concept of interoperability in the wrong direction, and the industry is finally changing course.

John’s Thoughts

“I think that people are coming to the realization that a one-size-fits-all kind of interoperability environment is something that not only isn’t going to happen, really isn’t the most productive way to think about this environment that we’re living in. So as we see these shows, as we talk to customers and prospects, as we talk to our partners, we’re hearing the same thing over and over again. We need to figure out how to have everything work together better rather than try to think about only one path and force everybody to adhere to that point of view.

You know, I think it impacts each and every person, but most particularly important to us is the issue around being able to deliver products that encourage health equity. You know, the kind of products that we have really are utilized by folks that aren’t necessarily as technologically savvy or economically as gifted as some of the larger organizations, and we’re able to still let them participate the very real way in the entire interoperability continuum to be able to really drive more information into the provider’s hands to help at the point of care.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS said on November 3 it acquired LookDeep Health, a computer vision company, and introduced iQueue for Virtual Care, its first product built on what it calls ambient intelligence. Terms were not disclosed. The product bundles Virtual Observation, Virtual Nursing and Virtual Medicine, and LeanTaaS says hospitals can build on compatible cameras and in-room devices already installed or deploy supported hardware. The company cited reported results from LookDeep deployments, including fall-rate reductions of more than 70%, and said LookDeep's technology was evaluated in peer-reviewed research published in Frontiers in Imaging.

  • 01LeanTaaS acquired LookDeep Health and launched iQueue for Virtual Care, combining Virtual Observation, Virtual Nursing and Virtual Medicine; acquisition terms were not disclosed.
  • 02Hospitals can build on compatible cameras and in-room devices already in place or deploy supported hardware, according to LeanTaaS, which did not name camera vendors.
  • 03LeanTaaS reported results from LookDeep deployments including fall-rate reductions of more than 70% and twice as much nursing contact, figures that are the company's own and not tied to named health systems.

Nov 3, 2026

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Royal Philips reported 8% comparable order intake growth for the third quarter of 2026, driven by Diagnosis & Treatment, with comparable sales up 3% to EUR 4.4 billion and an adjusted EBITA margin of 13.0%, up 70 basis points. The company reiterated its 2026 outlook for 3% to 4.5% comparable sales growth. Philips Respironics reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations related to its recall, and Philips recorded a EUR 288 million provision in the quarter, with payment expected in the first quarter of 2027 subject to final documentation.

  • 01Comparable order intake grew 8%, matching a year earlier, with Diagnosis & Treatment the driver; the equipment order book stands at about 40% of revenue.
  • 02Comparable sales rose 3% to EUR 4.4 billion, adjusted EBITA margin reached 13.0%, and free cash flow was EUR 384 million; the 2026 outlook was reiterated.
  • 03Philips Respironics reached an agreement in principle with the DOJ on previously disclosed recall investigations, and Philips recorded a EUR 288 million provision; the settlement is subject to final documentation.

Nov 3, 2026

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agreed to acquire most of Vantive's hemodialysis business for $125 million in base consideration, plus up to $45 million in contingent payments, with closing expected mid-2027. The deal includes hemodialysis concentrates, machines, water treatment systems, and Vantive's Medolla, Italy manufacturing facility; the combined business could generate $400-450 million annually, depending on various factors.

  • 01Rockwell Medical acquires Vantive's hemodialysis concentrates, AK 98 machines, water treatment systems, and one-million-square-foot Medolla, Italy manufacturing campus for $125 million base price plus up to $45 million contingent on revenue and EBITDA milestones.
  • 02Combined business targeted to generate $400-450 million in annual revenue depending on operating performance, exchange rates, market conditions and integration.
  • 03Vantive's dialyzer portfolio, including Theranova dialyzer for expanded hemodialysis, remains with Vantive; the company will focus on home dialysis and critical care after divestiture.

Nov 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512